FATE is an interesting company, just developing. There are about 480 thousand in cash, an annual loss of 173 thousand, Has 8 studies in 1 phase. Probably, it will “accumulate” one more year before significant phase studies (3), which corresponds to the negative scenario. And 2 in partnership with Janssen and Ono Pharma. Curious FT596 with rituximab and FT538 with...
Please review any tips or thoughts is helpful. 1 to 4 risk to reward Stop loss 69 Short term price target $78 Risking $2 for $8 a share.
3 to 4 weeks on the 30 min chart. Staying patient, hoping bullish wedge forms before the dead cat bounce swing. Some Bollinger band squeezes energy behind it. Let's see! NASDAQ:FATE
In this video I break down my watchlist for potential FDA dates to play in smaller cap pharma companies. Please note that this is not financial advise in any way. My Watchlist: $SESN $FATE $KLDO $AVXL $FSTX $LPCN $MITO Good Luck!
Looking to place some Leaps on FATE as hedge funds pile up on this biotech stock
Go long if prices take out today's high. Stop underneath the bear trap.
MRNA leading fate higher, MACD and RSI curling up, A+ setup, im very bullish biotech rn
Bullish Pennant Pros: Descending volume during formation PPS above 50MA and 200MA RS above 0, and ascending ATR Ascending R/R ratio above 5 200MA ascending 250RSI above 50 Price Target: PT = 145.41$
Hot sector, high tight flag, 10MA, VPA, Inside day NASDAQ:FATE
shorting this stock - FATE - for my own records.
Hey people, FATE THERAPEUTICS is in a very important moment in its history, we may have to do a higher history on the next session. It is in a fake bearish configuration with an aborted buyer's attempt and a high volume of sales at the end of the session. In the MULTI TIMEFRAME 15 5 1 Min sellers rejection on a sales volume, to take the direction of its last...
This price move could indicate a change in the trend, and may be a buy signal for investors. Tickeron A.I.dvisor found 46 similar cases, and 46 were successful. Based on this data, the odds of success are 90%. Current price $33.83 crossed the resistance line at $32.99 and is trading between $34.02 resistance and $32.99 resistance lines. Throughout the month of...